NEW YORK — Rosen Law Firm, renowned for championing global investor rights, has issued a reminder about the impending lead plaintiff deadline of December 13, 2024, for those who acquired securities from Edwards Lifesciences Corporation during the period of February 6, 2024, to July 24, 2024. This deadline is crucial for investors who believe they have suffered losses due to potential misinformation by Edwards Lifesciences regarding their financial forecasts and product performance.
Investors who have bought Edwards securities within this specified period may be eligible for compensation without the necessity of any out-of-pocket fees or costs through a contingency fee arrangement. This legal action addresses issues related to the company’s revenue forecasts, particularly concerning the performance of their central product, Transcatheter Aortic Valve Replacement (TAVR).
The lawsuit claims that Edwards Lifesciences may have misled investors with overly optimistic projections about their TAVR platform. The company had expressed strong confidence in their ability to expand market share by targeting untreated patient segments and emphasized substantial demand in markets they considered under-penetrated. However, as detailed facts became available, deviations from these expectations led to investor losses.
Rosen Law Firm encourages those affected to join the class action lawsuit. Interested parties can obtain more information or participate by contacting Phillip Kim, Esq. at the firm. It is important to note that unless a class is certified, individuals are not automatically represented by counsel unless they engage one. Investors can choose to hire a personal attorney or opt to stay uninvolved and inactive in the lawsuit at this stage.
The selection of legal counsel is critical. Rosen Law Firm highlights the importance of choosing qualified legal representation experienced in managing significant securities class actions. The firm prides itself on its track record, including securing the largest securities class action settlement against a Chinese company at the time and continuously being ranked high in securities class action settlements since 2013.
The firm has successfully reclaimed hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone. Lawrence Rosen, the founding partner, was recognized as a Titan of Plaintiffs’ Bar by legal industry observers in 2020. The firm’s expertise is backed by substantial peer recognition and its attorneys have garnered accolades from various prestigious directories.
Investors and interested parties are encouraged to stay informed about this case and can follow updates on various social media platforms where Rosen Law Firm maintains a presence.
While this notification serves as an attorney advertisement, it’s important to note that prior results achieved by Rosen Law Firm do not necessarily predict similar outcomes in future cases.
For further details or questions about this class action, contacts are as follows: Laurence Rosen, Esq., Phillip Kim, Esq., The Rosen Law Firm, P.A., located at 275 Madison Avenue, 40th Floor, New York, NY. They can be reached by phone or through their website.
Disclaimer: This article was automatically generated by Open AI. Facts, people, circumstances, and other details in the story may not be accurate. For corrections, retractions, or to request removal of content, please send an email to [email protected].